Skip to main content

Published locations for Ipilimumab may restore antitumor immunity after relapse from HSCT

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ipilimumab may restore antitumor immunity after relapse from HSCT

User login

  • Reset your password
  • /content/ipilimumab-may-restore-antitumor-immunity-after-relapse-hsct
  • /hematologynews/article/110302/aml/ipilimumab-may-restore-antitumor-immunity-after-relapse-hsct
  • /oncologypractice/article/110302/aml/ipilimumab-may-restore-antitumor-immunity-after-relapse-hsct
  • /hematology-oncology/article/110302/aml/ipilimumab-may-restore-antitumor-immunity-after-relapse-hsct